PDF (Español (España))
FLIP
EPUB (Español (España))
HTML (Español (España))
XML (Español (España))
Manuscripts sent to SALUTA Magazine must be original and unpublished and must not be simultaneously in the process of publication in other magazines, compilations or any other means of publication. The content of the publications and the links suggested in them are the sole responsibility of the authors and not of the METROPOLITAN UNIVERSITY OF EDUCATION, SCIENCE AND TECHNOLOGY
(UMECIT) or the magazine SALUTA. They are protected by international copyright laws as well as the logos of UMECIT AND SALUTA MAGAZINE, hence their reproduction is totally prohibited. The copyright will belong to the UMECIT.
Under a Creative Commons Attribution License authors may share work with acknowledgment of authorship of the work and initial publication in this journal.
Abstract
At the end of 2019, a new disease was detected, called COVID-19. Bupa Global Panama (2020) defines it as “COVID-19 is the infectious disease caused by the most recently discovered coronavirus. Both were unknown before the outbreak broke out in Wuhan (China) in December 2019 ”, whose consequences can be deadly. Although it is true that the family of coronaviruses is numerous, the new disease is caused by a strain of coronavirus, which until then was unknown, 2019-nCoV, which, in January 2020, was spreading across all continents, causing numerous infected people and causing many deaths, so on March 11, 2020. It is necessary to consider that currently, Diabetes is a comorbidity closely associated with complications during the treatment period of COVID-19; that, in turn, these complications are associated with sequelae and death of patients. This article analyzes this problem and how the issue of diabetes control has been addressed in times of pandemic.
Keywords:
References
Bupa Global Panamá. (Marzo 2020). Qué es el Coronavirus y su origen. Documento en línea disponible: https://www.bupasalud.com.pa/salud/coronavirus
Esparza S., Cepeda A., Salinas M., Lara A. (2014). Alteraciones del Sistema Inmune en Pacientes con Diabetes Mellitus. Revista Científica, tecnológica y humanística. Facultad de Medicina de la Universidad Autónoma de Coahuila, (N°37) Documento en línea disponible: http://www.cienciacierta.uadec.mx/2014/03/04/alteraciones-del-sistema-inmune-en-pacientes-con-diabetes-mellitus/
Gordón, I. (28 de junio de 2020). La Sindemia que vive Panamá en medio de la Covid-19. Diario La Estrella de Panamá. Documento en línea disponible en https://www.laestrella.com.pa/nacional/200628/sindemia-vive-panama-medio-covid
Pérez M., Gómez J., Diéguez R. (11 de abril 2020). Características clínico-epidemiológicas de la COVID-19. Revista Habanera de Ciencias Médicas. Recuperado el 18 de junio de 2021, de http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000200005&lng=es&tlng=es.
Rodríguez, R., Alonso C., Martínez G., Sánchez C., Menéndez E. (1 de Abril 2021). Consecuencias del Confinamiento por la COVID -19 en el perfil glucémico en Diabetes mellitus tipo 1. Revistas Elsevier. Recuperado el 6 de Julio de 2021, de https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-avance-resumen-consecuencias-del-confinamiento-por-covid-19-S2530016421000719
Rojas, K. (2020). La pandemia por la Covid-19 ha hecho que la Diabetes sea más difícil de manejar. Diario La Estrella de Panamá. Documento en línea disponible en https://www.laestrella.com.pa/cafe-estrella/salud/201113/pandemia-covid-19-hecho-diabetes-sea-dificil-manejar
Sevillano, E. (11 de Marzo de 2020). La OMS declara el brote de coronavirus pandemia global. Diario electrónico El País. Documento en línea disponible en https://elpais.com/sociedad/2020-03-11/la-oms-declara-el-brote-de-coronavirus-pandemia-global.html.
